1. An overview of hormonal directed pharmacotherapy for the treatment of prostate cancer;Mitsogianni;Expert Opin Pharmacother,2023
2. An F876L mutation in androgen receptor confers genetic and phenotypic resistance to MDV3100 (enzalutamide);Korpal;Cancer Discov,2013
3. AR splicing variants and resistance to AR targeting agents;Kanayama;Cancers (Basel),2021
4. Promotion of agonist activity of antiandrogens by the androgen receptor coactivator, ARA70, in human prostate cancer DU145 cells;Miyamoto;Proc Natl Acad Sci U S A,1998
5. Interaction of the putative androgen receptor-specific coactivator ARA70/ELE1alpha with multiple steroid receptors and identification of an internally deleted ELE1beta isoform;Alen;Mol Endocrinol,1999